Literature DB >> 27510226

Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients.

M Papo1, L Valeyrie-Allanore2, K Razazi1,3, G Carteaux1,3, P Wolkenstein2, O Chosidow2, C Brun-Buisson1,3, A Mekontso Dessap1,3, N de Prost1,3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 27510226     DOI： 10.1111/bjd.14934

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  2 in total

1.  Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.

Authors:  Megan H Noe; Misha Rosenbach; Rebecca A Hubbard; Arash Mostaghimi; Adela R Cardones; Jennifer K Chen; Jonathan Cotliar; Mark D P Davis; Arturo Dominguez; Lindy P Fox; Lauren C Hughey; Benjamin H Kaffenberger; Daniela Kroshinsky; Bernice Y Kwong; Daniel D Miller; Amy Musiek; Alex G Ortega-Loayza; Victoria R Sharon; Kanade Shinkai; Erika M Summers; Karolyn A Wanat; David A Wetter; Scott Worswick; David J Margolis; Joel M Gelfand; Robert G Micheletti
Journal:  JAMA Dermatol       Date:  2019-04-01       Impact factor: 10.282

2.  Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis.

Authors:  Hui Kai Koh; Stephanie Fook-Chong; Haur Yueh Lee
Journal:  JAMA Dermatol       Date:  2020-12-01       Impact factor: 10.282
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.